Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 10, 2026

Detection of CD40 Protein-Umbelliferone Interaction via Differential Scanning Fluorescence
05:30

Detection of CD40 Protein-Umbelliferone Interaction via Differential Scanning Fluorescence

Published on: March 1, 2024

Maximal 'CD80-uria' with minimal change.

Andreas D Kistler1, Jochen Reiser

  • 1Division of Nephrology and Hypertension, University of Miami Miller School of Medicine, Miami, Florida 33136, USA.

Kidney International
|July 16, 2010
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The role of suPAR and related proteins in kidney, heart diseases, and diabetes.

The Journal of clinical investigation·2026
Same author

Soluble urokinase receptor is a kidney-specific vasoconstrictor.

EBioMedicine·2025
Same author

Dysregulated Bone Marrow Contributes to Glomerular Injury through Soluble Factors.

Journal of the American Society of Nephrology : JASN·2025
Same author

Pathogenesis of Focal Segmental Glomerulosclerosis and Related Disorders.

Annual review of pathology·2025
Same author

Treatment of Podocytopathies: Risky Business and Our Personal Journey.

Journal of the American Society of Nephrology : JASN·2024
Same author

Circulating soluble urokinase plasminogen receptor is reduced by - and predicts early treatment response to therapeutic plasma exchange in septic shock.

Journal of critical care·2024
Same journal

KDIGO Life Cycle of Guideline Development Series Part 6: Bridging the Gap between Guidelines and Clinical Practice: The KDIGO Approach to Global Implementation and Education in Nephrology.

Kidney international·2026
Same journal

KDIGO Life Cycle of Guideline Development Series Part 5: Guideline updates and a living model for the future.

Kidney international·2026
Same journal

Crystal-Storing Histiocytosis Causing Severe AKI.

Kidney international·2026
Same journal

Peritoneal dialysis in a patient with extensive burn scarring.

Kidney international·2026
Same journal

COPA syndrome unmasked by anti-neutrophil cytoplasmic antibody-positive immune-complex nephritis.

Kidney international·2026
Same journal

Monitoring anti-nephrin antibodies in the management of recurrent diffuse podocytopathy.

Kidney international·2026
See all related articles

Urinary CD80 levels may help distinguish minimal-change disease from focal segmental glomerulosclerosis. This finding offers a potential new biomarker for early diagnosis in patients with these challenging kidney conditions.

Area of Science:

  • Nephrology
  • Immunology
  • Biomarker Discovery

Background:

  • Distinguishing minimal-change disease (MCD) from focal segmental glomerulosclerosis (FSGS) is clinically challenging, especially in early disease stages.
  • Accurate differentiation is crucial for appropriate patient management and treatment strategies.
  • Current diagnostic methods can be invasive and may not always provide definitive answers.

Discussion:

  • Garin et al. investigated urinary CD80 excretion as a potential diagnostic marker.
  • CD80, a protein expressed on podocytes, has been implicated in podocyte injury and effacement.
  • Previous studies noted CD80 expression in mouse models and human lupus nephritis.

Key Insights:

  • Elevated urinary CD80 levels were identified as a potential differentiator between MCD and FSGS.

More Related Videos

Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes
11:47

Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes

Published on: March 4, 2022

Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance
14:01

Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance

Published on: July 22, 2011

Related Experiment Videos

Last Updated: Jun 10, 2026

Detection of CD40 Protein-Umbelliferone Interaction via Differential Scanning Fluorescence
05:30

Detection of CD40 Protein-Umbelliferone Interaction via Differential Scanning Fluorescence

Published on: March 1, 2024

Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes
11:47

Using 2-Photon Microscopy to Quantify the Effects of Chronic Unilateral Ureteral Obstruction on Glomerular Processes

Published on: March 4, 2022

Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance
14:01

Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance

Published on: July 22, 2011

  • This non-invasive biomarker could aid in early and accurate diagnosis.
  • The findings suggest a shift towards molecular diagnostics in glomerular diseases.

    • Outlook:

    • Further clinical validation is required to establish urinary CD80 as a reliable diagnostic tool.
    • This biomarker may refine diagnostic algorithms for nephrotic syndrome.
    • Future research could explore therapeutic targeting of CD80 in relevant kidney diseases.